Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Syneron Medical Ltd (ELOS) Tops Q3 EPS by 3c
November 9, 2016 7:54 AM ESTSyneron Medical Ltd (Nasdaq: ELOS) reported Q3 EPS of $0.08, $0.03 better than the analyst estimate of $0.05. Revenue for the quarter came in at $71.5 million versus the consensus estimate of $68.08 million.
As of September 30, 2016, the Company's overall cash position, including cash and cash equivalents, short-term bank... More
